Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
University of Alabama at Birmingham
University of Alabama at Birmingham
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Johns Hopkins University
Novartis
Institut National de la Santé Et de la Recherche Médicale, France
University of Alabama at Birmingham
St. Jude Children's Research Hospital
AstraZeneca
Masonic Cancer Center, University of Minnesota
AstraZeneca
Johns Hopkins University
Boston Children's Hospital
West China Hospital
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
AstraZeneca
Pasithea Therapeutics Corp.
Stanford University
Massachusetts General Hospital
Healx Limited
Massachusetts General Hospital
Johns Hopkins University
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Assistance Publique - Hôpitaux de Paris
Cedars-Sinai Medical Center
Ann & Robert H Lurie Children's Hospital of Chicago
SpringWorks Therapeutics, Inc.
Children's Hospital Medical Center, Cincinnati
Masonic Cancer Center, University of Minnesota
The Hospital for Sick Children
Vanderbilt University
Children's National Research Institute
Vanderbilt University